The Role of Serotonin (5-Hydroxytryptamine1A and 1B) Receptors in Prostate Cancer Cell Proliferation

Journal of Urology

Volumn 176, Issue 4, 2006, Pages 1648-1653

  Siddiqui, Emad J ^a   Shabbir, Majid ^a   Mikhailidis, Dimitri P ^a   Thompson, Cecil S ^a   Mumtaz, Faiz H ^a,b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

gene expression; prostate; prostatic neoplasms; serotonin

Indexed keywords

1 (2 METHOXYPHENYL) 4 (4 PHTHALIMIDOBUTYL)PIPERAZINE; 2,3,6,7 TETRAHYDRO 1' METHYL 5 [[2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL) 4 BIPHENYLYL]CARBONYL]SPIRO[FURO[2,3 F]INDOLE 3,4' PIPERIDINE]; 4 AMINO 5 CHLORO 2 METHOXYBENZOIC ACID 3 PIPERIDINOPROPYL ESTER; AZASETRON; CRYSTAL VIOLET; KETANSERIN; SEROTONIN; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR; SEROTONIN 1B ANTAGONIST; SEROTONIN 1B RECEPTOR; SEROTONIN 1D ANTAGONIST; SEROTONIN 2 ANTAGONIST; SEROTONIN 3 ANTAGONIST; SEROTONIN 4 ANTAGONIST;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER HORMONE THERAPY; CANCER TISSUE; CELL ASSAY; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INCUBATION TIME; MALE; PRIORITY JOURNAL; PROSTATE CANCER; WESTERN BLOTTING;

APOPTOSIS; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; MALE; PROSTATIC NEOPLASMS; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN AGENTS; SEROTONIN ANTAGONISTS;

EID: 33748104741     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2006.06.087     Document Type: Article

References (20)

1. di Sant'Agnese P.A. Neuroendocrine cells of the prostate and neuroendocrine differentiation in prostatic carcinoma. a review of morphologic aspects. Urology 51 (1998) 121
2. Siddiqui E.J., Thompson C.S., Mikhailidis D.P., and Mumtaz F.H. The role of serotonin in tumour growth. (review). Oncol Rep 14 (2005) 1593
3. Silvestris N., Leone B., Numico G., Lorusso V., and De Lena M. Present status and perspectives in the treatment of hormone-refractory prostate cancer. Oncology 69 (2005) 273
4. Takuwa N., Ganz M., Takuwa Y., Sterzel R.B., and Rasmussen H. Studies of the mitogenic effect of serotonin in rat renal mesangial cells. Am J Physiol 257 (1989) F431
5. Yazaki T., Inage H., Iizumi T., Koyama A., Kanoh S., Koiso K., et al. Studies on platelet function in patients with prostatic cancer. Preliminary report. Urology 30 (1987) 60
6. Dey R.D., and Hoffpauir J. Ultrastructural immunocytochemical localization of 5-hydroxytryptamine in gastric enterochromaffin cells. J Histochem Cytochem 32 (1984) 661
7. Ishizuka J., Beauchamp R.D., Townsend C.M., Greeley G.H., and Thompson J.C. Receptor-mediated autocrine growth-stimulatory effect of 5-hydroxytryptamine on cultured human pancreatic carcinoid cells. J Cell Physiol 150 (1992) 1
8. Cattaneo M.G., Fesce R., and Vicentini L.M. Mitogenic effect of serotonin in human small cell lung carcinoma cells via both 5-HT1A and 5-HT1D receptors. Eur J Pharmacol 291 (1995) 209
9. Tutton P.J., and Barkla D.H. Influence of inhibitors of serotonin uptake on intestinal epithelium and colorectal carcinomas. Br J Cancer 46 (1982) 260
10. Hoyer D., Clarke D.E., Fozard J.R., Hartig P.R., Martin G.R., Mylecharane E.J., et al. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 46 (1994) 157
11. Abdul M., Anezinis P.E., Logothetis C.J., and Hoosein N.M. Growth inhibition of human prostatic carcinoma cell lines by serotonin antagonists. Anticancer Res 14 (1994) 1215
12. Abdul M., Logothetis C.J., and Hoosein N.M. Growth-inhibitory effects of serotonin uptake inhibitors on human prostate carcinoma cell lines. J Urol 154 (1995) 247
13. Dizeyi N., Bjartell A., Nilsson E., Hansson J., Gadaleanu V., Cross N., et al. Expression of serotonin receptors and role of serotonin in human prostate cancer tissue and cell lines. Prostate 59 (2004) 328
14. Jiborn T., Bjartell A., and Abrahamsson P.A. Neuroendocrine differentiation in prostatic carcinoma during hormonal treatment. Urology 51 (1998) 585
15. Fanburg B.L., and Lee S.L. A new role for an old molecule. serotonin as a mitogen. Am J Physiol 272 (1997) L795
16. Fenrick R., Pou C., Beliveau M., and Fargin A. The human 5-hydroxytryptamine 1A receptor differentially modulates phospholipase C and adenylyl cyclase activities. Gen Pharmacol 27 (1996) 263
17. Strother J.M., Beer T.M., and Dreicer R. Novel cytotoxic and biological agents for prostate cancer. where will the money be in 2005?. Eur J Cancer 41 (2005) 954
18. Robertson C.N., Roberson K.M., Padilla G.M., O'Brien E.T., Cook J.M., Kim C.S., et al. Induction of apoptosis by diethylstilbestrol in hormone-insensitive prostate cancer cells. J Natl Cancer Inst 88 (1996) 908
19. Siddiqui E.J., Shabbir M., Thompson C.S., Mumtaz F.H., and Mikhailidis D.P. Growth inhibitory effect of doxazosin on prostate and bladder cancer cells. Is the serotonin receptor pathway involved? Anticancer Res 25 (2005) 4281
20. Khan M.A., Thompson C.S., Dashwood M.R., Mumtaz F.H., Mikhailidis D.P., and Morgan R.J. Doxazosin modifies serotonin-mediated rabbit urinary bladder contraction. Potential clinical relevance. Urol Res 28 (2000) 116